Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants: A single institution study

A. J. Matas, V. A. Tellis, T. Quinn, A. Principe, R. Soberman, M. Mallis, D. Glicklich, F. Veith

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The importance of HLA matching for cadaver kidney transplantation remains controversial. In some studies, matching has been reported to affect both short- and long-term graft survival. We studied the short- (cyclosporine and prednisone immunosuppression) and long- (azathioprine and prednisone immunosuppression)-term patient and graft survival for recipients of 0 antigen-matched transplants and compared them with survival in those matched for ≥ 1 antigen. All patients were transplanted at the same institution and the HLA typing was done by a single laboratory. For first cadaver kidney recipients (n = 384) there were no significant differences in either short- or long-term patient or graft survival between 0 antigen-matched and ≥ 1 antigen-matched recipients. In fact, 1-year graft survival for the 0 antigen-matched, cyclosporine-immunosuppressed recipient was 87%. Our results compare favorably with all reported data on patient and graft survival where matching is used for kidney allocation. We believe that matching should not be given increased importance in kidney distribution.

Original languageEnglish (US)
Pages (from-to)22-26
Number of pages5
JournalClinical Transplantation
Volume3
Issue number1
StatePublished - 1989

Fingerprint

Graft Survival
Cadaver
Transplants
Kidney
Antigens
Prednisone
Immunosuppression
Cyclosporine
Histocompatibility Testing
Azathioprine
Kidney Transplantation
Survival

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Matas, A. J., Tellis, V. A., Quinn, T., Principe, A., Soberman, R., Mallis, M., ... Veith, F. (1989). Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants: A single institution study. Clinical Transplantation, 3(1), 22-26.

Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants : A single institution study. / Matas, A. J.; Tellis, V. A.; Quinn, T.; Principe, A.; Soberman, R.; Mallis, M.; Glicklich, D.; Veith, F.

In: Clinical Transplantation, Vol. 3, No. 1, 1989, p. 22-26.

Research output: Contribution to journalArticle

Matas, AJ, Tellis, VA, Quinn, T, Principe, A, Soberman, R, Mallis, M, Glicklich, D & Veith, F 1989, 'Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants: A single institution study', Clinical Transplantation, vol. 3, no. 1, pp. 22-26.
Matas, A. J. ; Tellis, V. A. ; Quinn, T. ; Principe, A. ; Soberman, R. ; Mallis, M. ; Glicklich, D. ; Veith, F. / Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants : A single institution study. In: Clinical Transplantation. 1989 ; Vol. 3, No. 1. pp. 22-26.
@article{32445390428c410b9785d2c5a1f5f2f2,
title = "Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants: A single institution study",
abstract = "The importance of HLA matching for cadaver kidney transplantation remains controversial. In some studies, matching has been reported to affect both short- and long-term graft survival. We studied the short- (cyclosporine and prednisone immunosuppression) and long- (azathioprine and prednisone immunosuppression)-term patient and graft survival for recipients of 0 antigen-matched transplants and compared them with survival in those matched for ≥ 1 antigen. All patients were transplanted at the same institution and the HLA typing was done by a single laboratory. For first cadaver kidney recipients (n = 384) there were no significant differences in either short- or long-term patient or graft survival between 0 antigen-matched and ≥ 1 antigen-matched recipients. In fact, 1-year graft survival for the 0 antigen-matched, cyclosporine-immunosuppressed recipient was 87{\%}. Our results compare favorably with all reported data on patient and graft survival where matching is used for kidney allocation. We believe that matching should not be given increased importance in kidney distribution.",
author = "Matas, {A. J.} and Tellis, {V. A.} and T. Quinn and A. Principe and R. Soberman and M. Mallis and D. Glicklich and F. Veith",
year = "1989",
language = "English (US)",
volume = "3",
pages = "22--26",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Short- and long-term graft survival with 0 antigen-matched first cadaver renal transplants

T2 - A single institution study

AU - Matas, A. J.

AU - Tellis, V. A.

AU - Quinn, T.

AU - Principe, A.

AU - Soberman, R.

AU - Mallis, M.

AU - Glicklich, D.

AU - Veith, F.

PY - 1989

Y1 - 1989

N2 - The importance of HLA matching for cadaver kidney transplantation remains controversial. In some studies, matching has been reported to affect both short- and long-term graft survival. We studied the short- (cyclosporine and prednisone immunosuppression) and long- (azathioprine and prednisone immunosuppression)-term patient and graft survival for recipients of 0 antigen-matched transplants and compared them with survival in those matched for ≥ 1 antigen. All patients were transplanted at the same institution and the HLA typing was done by a single laboratory. For first cadaver kidney recipients (n = 384) there were no significant differences in either short- or long-term patient or graft survival between 0 antigen-matched and ≥ 1 antigen-matched recipients. In fact, 1-year graft survival for the 0 antigen-matched, cyclosporine-immunosuppressed recipient was 87%. Our results compare favorably with all reported data on patient and graft survival where matching is used for kidney allocation. We believe that matching should not be given increased importance in kidney distribution.

AB - The importance of HLA matching for cadaver kidney transplantation remains controversial. In some studies, matching has been reported to affect both short- and long-term graft survival. We studied the short- (cyclosporine and prednisone immunosuppression) and long- (azathioprine and prednisone immunosuppression)-term patient and graft survival for recipients of 0 antigen-matched transplants and compared them with survival in those matched for ≥ 1 antigen. All patients were transplanted at the same institution and the HLA typing was done by a single laboratory. For first cadaver kidney recipients (n = 384) there were no significant differences in either short- or long-term patient or graft survival between 0 antigen-matched and ≥ 1 antigen-matched recipients. In fact, 1-year graft survival for the 0 antigen-matched, cyclosporine-immunosuppressed recipient was 87%. Our results compare favorably with all reported data on patient and graft survival where matching is used for kidney allocation. We believe that matching should not be given increased importance in kidney distribution.

UR - http://www.scopus.com/inward/record.url?scp=0024356543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024356543&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0024356543

VL - 3

SP - 22

EP - 26

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 1

ER -